MedTrace Logo

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

NCT02661958 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 726

Last updated 2019-09-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the superiority in efficacy and assess safety and tolerability of the products S6G5T-3 and S6G5T-1 as compared to their respective active components or the vehicle for the treatment of acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

S6G5T-3

once a day topical cream

DRUG

S6G5T-1

once a day topical cream

DRUG

S6G5T-5

once a day topical cream

DRUG

S6G5T-6

once a day topical cream

DRUG

S6G5T-7

once a day topical cream

DRUG

S6G5T-8

once a day topical cream

Sponsors & Collaborators

  • Accelovance

    collaborator INDUSTRY

  • Sol-Gel Technologies, Ltd.

    lead INDUSTRY

Principal Investigators

  • Piyush Sheladia, M.S. · Accelovance

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02661958 on ClinicalTrials.gov